Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.79 - $1.14 $820 - $1,184
1,039 Added 4.95%
22,028 $22,000
Q4 2023

Feb 14, 2024

BUY
$1.02 - $2.57 $1,635 - $4,119
1,603 Added 8.27%
20,989 $23,000
Q3 2023

Nov 14, 2023

BUY
$2.52 - $5.69 $20,626 - $46,572
8,185 Added 73.07%
19,386 $50,000
Q2 2023

Aug 14, 2023

BUY
$5.0 - $7.66 $56,005 - $85,799
11,201 New
11,201 $61,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $40.5M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.